BRIEF-Seres Therapeutics Announces Two Transactions To Strengthen Balance Sheet, Reduce On-Going Lease Costs And Extend Projected Operating Cash Runway Well Into The First Quarter Of 2027

Seres Therapeutics Inc

MCRB

0.00

June 5 (Reuters) - Seres Therapeutics Inc MCRB.O:

SERES THERAPEUTICS ANNOUNCES TWO TRANSACTIONS TO STRENGTHEN BALANCE SHEET, REDUCE ON-GOING LEASE COSTS AND EXTEND PROJECTED OPERATING CASH RUNWAY WELL INTO THE FIRST QUARTER OF 2027
SERES THERAPEUTICS - NESTLÉ HEALTH SCIENCE TO PAY SERES $25 MILLION IN 2026 FOR VOWST MILESTONE BUY-OUT
SERES THERAPEUTICS - RESTRUCTURES LEASE TO REDUCE ANNUAL FACILITY CASH COSTS AND LONG-TERM LEASE LIABILITY

Source text: ID:nGNX7gPcgs

Further company coverage: MCRB.O

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.